Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease
Related Experiment Video
Updated: Mar 1, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Rong-Hong Ma1, Yao Zhang2, Xiao-Yue Hong3
1Department of Laboratory Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Abstract:
As a major microtubule-associated protein, tau plays an important role in promoting microtubule assembly and stabilizing microtubules. In Alzheimer's disease (AD) and other tauopathies, the abnormally hyperphosphorylated tau proteins are aggregated into paired helical filaments and accumulated in the neurons with the form of neurofibrillary tangles. An imbalanced regulation in protein kinases and protein phosphatases is the direct cause of tau hyperphosphorylation. Among various kinases and phosphatases, glycogen synthase kinase-3β (GSK-3β) and protein phosphatase 2A (PP2A) are the most implicated. Accumulation of the hyperphosphorylated tau induces synaptic toxicity and cognitive impairments. Here, we review the upstream factors or pathways that can regulate GSK-3β or PP2A activity mainly based on our recent findings. We will also discuss the mechanisms that may underlie tau-induced synaptic toxicity.
Insights
Abnormal tau protein hyperphosphorylation, driven by kinases like GSK-3β and phosphatases like PP2A, causes neurofibrillary tangles in Alzheimer's disease (AD), leading to cognitive decline.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Tau is a microtubule-associated protein crucial for neuronal structure.
- Hyperphosphorylated tau aggregates into neurofibrillary tangles in Alzheimer's disease (AD) and tauopathies.
- Dysregulation of protein kinases and phosphatases, particularly GSK-3β and PP2A, causes tau hyperphosphorylation.
Purpose of the Study:
- To review upstream regulators of glycogen synthase kinase-3β (GSK-3β) and protein phosphatase 2A (PP2A) activity.
- To discuss mechanisms of tau-induced synaptic toxicity.
- To highlight recent findings on tau phosphorylation pathways.
Main Methods:
- Literature review focusing on upstream factors regulating GSK-3β and PP2A.
- Analysis of pathways involved in tau hyperphosphorylation.
- Discussion of mechanisms linking hyperphosphorylated tau to synaptic dysfunction.
Main Results:
- Identified key upstream regulators influencing GSK-3β and PP2A activities.
- Detailed pathways contributing to tau hyperphosphorylation.
- Elucidated potential mechanisms of tau-mediated synaptic toxicity.
Conclusions:
- Imbalanced regulation of GSK-3β and PP2A is central to tauopathies like AD.
- Understanding these regulatory pathways is critical for developing therapeutic strategies.
- Further research into tau-induced synaptic toxicity may reveal new treatment targets.
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Microtubule Associated Proteins (MAPs)
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Parkinson's Disease: Overview

